Caribou Biosciences announced the resignation of CFO Jason O'Byrne effective September 27, 2024, and the appointment of Ryan Fischesser as interim principal financial officer, who will receive 25,000 restricted stock units that vest in 2025.
AI Assistant
CARIBOU BIOSCIENCES INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.